Literature DB >> 16476050

Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice.

Monica Froicu1, Yan Zhu, Margherita T Cantorna.   

Abstract

The vitamin D receptor (VDR) is a nuclear receptor expressed in a number of different cells of the immune system. This study was performed to determine the effect of VDR deficiency on immune function and inflammation of the gastrointestinal tract in a model of inflammatory bowel disease, namely interleukin-10 (IL-10) knockout mice. IL-10 knockout mice were generated which either could or could not respond to vitamin D (double IL-10/VDR knockout; DKO). The distribution and function of lymphocytes in both the primary and secondary lymphoid organs were compared and determined as a function of the severity of intestinal inflammation. DKO mice had normal thymic development and peripheral T-cell numbers at 3 weeks of age, but a week after intestinal disease was detected the thymus was dysplastic with a reduction in cellularity. The atrophy was coupled with increased apoptosis. The spleen weight of DKO mice increased as a result of the accumulation of red blood cells; however, there was a 50% reduction in the numbers of T and B cells. Conversely, the mesenteric lymph nodes were enlarged and contained increased numbers of lymphocytes. The T cells from DKO mice were of a memory phenotype and were hyporesponsive to T-cell receptor stimulation. Colitis in the DKO mice was associated with local and high expression of IL-2, interferon-gamma, IL-1beta, tumour necrosis factor-alpha and IL-12. The primary and secondary lymphoid organs in DKO mice are profoundly altered as a consequence of the fulminating inflammation in the gastrointestinal tract. VDR expression is required for the T cells and other immune cells to control inflammation in the IL-10 KO mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476050      PMCID: PMC1782241          DOI: 10.1111/j.1365-2567.2005.02290.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

Review 1.  T-cell development and the CD4-CD8 lineage decision.

Authors:  Ronald N Germain
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

2.  The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.

Authors:  Terrence F Meehan; Hector F DeLuca
Journal:  Arch Biochem Biophys       Date:  2002-12-15       Impact factor: 4.013

3.  Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease.

Authors:  Yan Zhu; Brett D Mahon; Monica Froicu; Margherita T Cantorna
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

Review 4.  Vitamin D: its role and uses in immunology.

Authors:  H F Deluca; M T Cantorna
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

5.  Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.

Authors:  O Ludwiczek; E Vannier; I Borggraefe; A Kaser; B Siegmund; C A Dinarello; H Tilg
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

6.  A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases.

Authors:  Monica Froicu; Veronika Weaver; Thomas A Wynn; Mary Ann McDowell; Jo Ellen Welsh; Margherita T Cantorna
Journal:  Mol Endocrinol       Date:  2003-09-18

Review 7.  The immunological and genetic basis of inflammatory bowel disease.

Authors:  Gerd Bouma; Warren Strober
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

Review 8.  Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands.

Authors:  Luciano Adorini; Giuseppe Penna; Nadia Giarratana; Andrea Roncari; Susana Amuchastegui; Kenn C Daniel; Milan Uskokovic
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

9.  Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice.

Authors:  A Giulietti; C Gysemans; K Stoffels; E van Etten; B Decallonne; L Overbergh; R Bouillon; C Mathieu
Journal:  Diabetologia       Date:  2004-01-31       Impact factor: 10.122

10.  Vitamin D status in children, adolescents, and young adults with Crohn disease.

Authors:  Timothy A Sentongo; Edisio J Semaeo; Nicolas Stettler; David A Piccoli; Virginia A Stallings; Babette S Zemel
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

View more
  64 in total

Review 1.  Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes.

Authors:  Amrita Kabi; Kourtney P Nickerson; Craig R Homer; Christine McDonald
Journal:  Inflamm Bowel Dis       Date:  2011-09-20       Impact factor: 5.325

2.  Intrinsic requirement for the vitamin D receptor in the development of CD8αα-expressing T cells.

Authors:  Danny Bruce; Margherita T Cantorna
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

3.  KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.

Authors:  Jeremy A Goettel; Holly M Scott Algood; Danyvid Olivares-Villagómez; M Kay Washington; Rupesh Chaturvedi; Keith T Wilson; Luc Van Kaer; D Brent Polk
Journal:  Gastroenterology       Date:  2010-09-25       Impact factor: 22.682

4.  Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic?

Authors:  Scott T Weiss
Journal:  J Allergy Clin Immunol       Date:  2011-03-16       Impact factor: 10.793

Review 5.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 6.  Current evidence for vitamin D in intestinal function and disease.

Authors:  Mohammadhossein Hassanshahi; Paul H Anderson; Cyan L Sylvester; Andrea M Stringer
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-31

7.  Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease.

Authors:  Manabu Araki; Shinichiro Shinzaki; Takuya Yamada; Shoko Arimitsu; Masato Komori; Narihiro Shibukawa; Akira Mukai; Sachiko Nakajima; Kazuo Kinoshita; Shinji Kitamura; Yoko Murayama; Hiroyuki Ogawa; Yuichi Yasunaga; Masahide Oshita; Hiroyuki Fukui; Eiji Masuda; Masahiko Tsujii; Satoshi Hiyama; Takahiro Inoue; Hideki Iijima; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2017-02-06       Impact factor: 7.527

Review 8.  Metabolites: deciphering the molecular language between DCs and their environment.

Authors:  Lucía Minarrieta; Peyman Ghorbani; Tim Sparwasser; Luciana Berod
Journal:  Semin Immunopathol       Date:  2016-12-05       Impact factor: 9.623

Review 9.  The paradoxical effects of vitamin D on type 1 mediated immunity.

Authors:  Margherita T Cantorna; Sanhong Yu; Danny Bruce
Journal:  Mol Aspects Med       Date:  2008-05-04

Review 10.  Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review.

Authors:  Krista M Reich; Richard N Fedorak; Karen Madsen; Karen I Kroeker
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.